replicative immortality and telomerase

Imagine a shoelace whose plastic tip protects the lace from fraying. Every time you use the lace, the tip wears down a little; once it is gone, the lace itself starts to unravel. Your chromosomes have such tips, called telomeres, and each time a cell divides they get a little shorter. When they wear down too far, the cell stops dividing and retires. This built-in limit is one of the body's natural defenses against runaway growth — and cancer cells find a way around it.

More precisely, normal cells can divide only a limited number of times (roughly the Hayflick limit) before their telomeres become too short, at which point they enter a permanent non-dividing state. Most adult cells make little or none of the enzyme telomerase, which can rebuild telomeres. Cancer cells achieve 'replicative immortality' — the ability to divide endlessly — most commonly by switching telomerase back on, so the protective tips are continually restored and the cell never hits its retirement limit. (A minority of cancers use a different telomere-lengthening trick instead.)

This matters because replicative immortality is one of the hallmarks of cancer: it lets a tumor cell line keep dividing essentially forever, which is exactly what you do not want a rogue cell to do. It also makes telomerase a tempting drug target, since healthy cells mostly do not rely on it. A caution against hype: reactivating telomerase is not what 'causes' cancer on its own, and switching telomerase on in healthy cells is not a proven path to longer life — telomeres are just one of many factors in aging, and tampering with this system carries its own cancer risks.